Status:

WITHDRAWN

Randomized Study on the Effects of Moderate Anaemia in Free Microvascular Tissue Transfer

Lead Sponsor:

University of Zurich

Conditions:

Open Fracture of Foot

Tumor

Eligibility:

All Genders

18+ years

Brief Summary

The evaluation of Perfusion of free flaps in patients with moderate anaemia and possible reduction of the transfusion threshold. * Trial with surgical intervention

Detailed Description

In study group 1 patients will be kept at a hematocrit level below 28% and only receive transfusions if symptomatic or the fall below 25%. Patients in group 2 will receive transfusions to reach a hema...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • planned defect reconstruction with free flap and preoperative hematocrit of 28% or below
  • Exclusion criteria:
  • coagulation disorder
  • Jehovah's witness
  • iodine allergy
  • renal or hepatic insufficiency

Exclusion

    Key Trial Info

    Start Date :

    May 1 2013

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    January 1 2018

    Estimated Enrollment :

    Patients enrolled

    Trial Details

    Trial ID

    NCT01848431

    Start Date

    May 1 2013

    End Date

    January 1 2018

    Last Update

    November 10 2020

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University Hospital Zurich, Center for Reconstructive Surgery

    Zurich, Canton of Zurich, Switzerland, 8091